Both of those varieties can result in too much daytime sleepiness. Research suggest that modafinil may be a promising drug that may minimize both equally daytime sleepiness and myotonia alone, without considerable cardiac conduction effects, which can be critical for individuals with myotonic dystrophy who often have underlying cardiac difficulties